Articles that tag NSP but are mainly about other companies.
Severe earnings collapse from $171.4M (2023) to $91M (2024) to $7M loss (2025) due to healthcare cost pressures. Dividend payout ratio unsustainable at 2x adjusted 2025 earnings and projected to exceed 2026 profits. Turnaround uncertain and dividend sustainability questionable.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
